메뉴 건너뛰기




Volumn 7, Issue 7, 2006, Pages 505-507

Cyclooxygenase inhibitors: A never ending story?;Gli inibitori delle ciclossigenasi: Una storia infinita?

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; VALDECOXIB; ISOPROTEIN; ISOXAZOLE DERIVATIVE; LACTONE; PROSTAGLANDIN SYNTHASE; PYRAZOLE DERIVATIVE; SULFONAMIDE; SULFONE;

EID: 33750137134     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (5)
  • 1
    • 9644253392 scopus 로고    scopus 로고
    • E-mails suggest Merck knew Vioxx's dangers at early stage
    • November 1
    • Matthews AW, Martinez B. E-mails suggest Merck knew Vioxx's dangers at early stage. Wall Street Journal, November 1, 2004.
    • (2004) Wall Street Journal
    • Matthews, A.W.1    Martinez, B.2
  • 2
    • 33845480368 scopus 로고    scopus 로고
    • CBS BEWS. FDA: Harsh criticism from within
    • CBS BEWS. FDA: Harsh criticism from within. http://www.cbsnews.com/ storie/2005/02/15/60II/printable674293.shtml
  • 3
    • 0035934070 scopus 로고    scopus 로고
    • Risk of cardiovascular events associated with selective COX-2 inhibitors
    • Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001; 286: 954-9.
    • (2001) JAMA , vol.286 , pp. 954-959
    • Mukherjee, D.1    Nissen, S.E.2    Topol, E.J.3
  • 4
    • 20544466390 scopus 로고    scopus 로고
    • The lessons of Vioxx: Drug safety and sales
    • Waxman H. The lessons of Vioxx: drug safety and sales. N Engl J Med 2005; 352: 2576-8.
    • (2005) N Engl J Med , vol.352 , pp. 2576-2578
    • Waxman, H.1
  • 5
    • 33845473922 scopus 로고    scopus 로고
    • Il caso rofecoxib: Ancora molto da imparare
    • Il caso rofecoxib: ancora molto da imparare. Bollettino di Informazione sui Farmaci 2004; 11: 181-2.
    • (2004) Bollettino Di Informazione Sui Farmaci , vol.11 , pp. 181-182


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.